Exact Mass: 419.0614514

Exact Mass Matches: 419.0614514

Found 117 metabolites which its exact mass value is equals to given mass value 419.0614514, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Prosulfuron

Prosulfuron

C15H16F3N5O4S (419.08750520000007)


CONFIDENCE standard compound; INTERNAL_ID 2617

   

ZOPOLRESTAT

2-(4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4-dihydrophthalazin-1-yl)acetic acid

C19H12F3N3O3S (419.0551438)


C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor D007004 - Hypoglycemic Agents D004791 - Enzyme Inhibitors

   

S-(2,2-Dichloro-1-hydroxy)ethyl glutathione

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2,2-dichloro-1-hydroxyethyl)sulfanyl]ethyl]-C-hydroxycarbonimidoyl}butanoic acid

C12H19Cl2N3O7S (419.03207240000006)


This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.

   

Nitrobenzylthioinosine

S-(4-Nitrobenzyl)-6-thioinosine

C17H17N5O6S (419.08995020000003)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels Nitrobenzylthioinosine is an ENT1 transporter inhibitor that binds to ENT1 transporter with high affinity. Nitrobenzylthioinosine is a photoaffinity probe for adenosine uptake sites in brain. Nitrobenzylthioinosine can cross the blood-brain barrier[1][2][3]. Nitrobenzylthioinosine is an ENT1 transporter inhibitor that binds to ENT1 transporter with high affinity. Nitrobenzylthioinosine is a photoaffinity probe for adenosine uptake sites in brain. Nitrobenzylthioinosine can cross the blood-brain barrier[1][2][3].

   

[3-[1-Formyl-2-(2-furanyl)ethenyl]]-2-(2-furanyl)-5-(2-furanylmethylene)-4,5-dihydro-a-methyl-4-oxo-1H-pyrrole-1-acetic acid, 9CI

2-[(2E)-5-(furan-2-yl)-4-[(1E)-1-(furan-2-yl)-3-oxoprop-1-en-2-yl]-2-(furan-2-ylmethylidene)-3-oxo-2,3-dihydro-1H-pyrrol-1-yl]propanoic acid

C23H17NO7 (419.1004972)


[3-[1-Formyl-2-(2-furanyl)ethenyl]]-2-(2-furanyl)-5-(2-furanylmethylene)-4,5-dihydro-a-methyl-4-oxo-1H-pyrrole-1-acetic acid, 9CI is a maillard product from reaction of L-alanine and 2-Furancarboxaldehyde FTR29-ZFTR29-Z

   

Cyanidin 3-arabinoside

3-{[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium

C20H19O10+ (419.09781740000005)


Isolated from numerous plant subspecies including red pears and apples. Cyanidin 3-arabinoside is found in many foods, some of which are common grape, american cranberry, blackcurrant, and lingonberry. Cyanidin 3-arabinoside is found in american cranberry. Cyanidin 3-arabinoside is isolated from numerous plant species including red pears and apples.

   

Cyanidin 3-xyloside

3-{[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1lambda4-chromen-1-ylium

C20H19O10+ (419.09781740000005)


Isolated from apples. Cyanidin 3-xyloside is found in many foods, some of which are pomes, summer grape, apple, and black chokeberry. Cyanidin 3-xyloside is found in american cranberry. Cyanidin 3-xyloside is isolated from apples.

   

Cyanidin 7-arabinoside

[(7E)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7H-chromen-7-ylidene](3,4,5-trihydroxyoxan-2-yl)oxidanium

C20H19O10+ (419.09781740000005)


Isolated from the apple tree Malus species Cyanidin 7-arabinoside is found in malus (crab apple) and pomes. Cyanidin 7-arabinoside is found in pomes. Cyanidin 7-arabinoside is isolated from the apple tree Malus sp.

   

2-Chloro-N-[1-[(2R)-2,3-dihydroxypropyl]-2-oxo-3,4-dihydroquinolin-3-yl]-6H-thieno[2,3-b]pyrrole-5-carboxamide

2-Chloro-N-[1-[(2R)-2,3-dihydroxypropyl]-1,2,3,4-tetrahydro-2-oxo-3-quinolinyl]-6H-thieno[2,3-b]pyrrole-5-carboxamide

C19H18ClN3O4S (419.07064980000007)


   

Methyl 5-(benzylcarbamoylamino)-3-(2,6-dichlorophenyl)-1,2-oxazole-4-carboxylate

Methyl 5-(benzylcarbamoylamino)-3-(2,6-dichlorophenyl)-1,2-oxazole-4-carboxylic acid

C19H15Cl2N3O4 (419.04395700000003)


   

4-Nitrobenzylthioinosine

2-(Hydroxymethyl)-5-(6-{[(4-nitrophenyl)methyl]sulphanyl}-9H-purin-9-yl)oxolane-3,4-diol

C17H17N5O6S (419.08995020000003)


   

Nitrobenzyl-6-thioinosine

9-[2-benzyl-3,4-dihydroxy-5-(hydroxymethyl)-3-nitrooxolan-2-yl]-6,9-dihydro-3H-purine-6-thione

C17H17N5O6S (419.08995020000003)


   

9-[(2R,3R,4S,5S)-3,4-Dihydroxy-5-[(4-nitrophenyl)methylsulfanylmethyl]oxolan-2-yl]-1H-purin-6-one

9-[3,4-dihydroxy-5-({[(4-nitrophenyl)methyl]sulfanyl}methyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C17H17N5O6S (419.08995020000003)


   

Cyanidin 3-O-alpha-L-arabinoside

3-{[(2S,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium

C20H19O10 (419.09781740000005)


Cyanidin 3-o-alpha-l-arabinoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Cyanidin 3-o-alpha-l-arabinoside can be found in cocoa bean and highbush blueberry, which makes cyanidin 3-o-alpha-l-arabinoside a potential biomarker for the consumption of these food products.

   
   

Glucoerypestrin

3-Methoxycarbonylpropyl glucosinolate

C12H21NO11S2 (419.0555996)


   
   

Cyanidin 3-o-alpha-L-arabinopyranoside

Cyanidin 3-o-alpha-L-arabinopyranoside

C20H19O10 (419.09781740000005)


   

Rosacyanin B

11- (3,4-Dihydroxyphenyl) -4,5,8-trihydroxy-2-oxo-2H-1,6-dioxa-10-oxoniabenzo [ cd ] pyrene

C22H11O9 (419.0403056)


   

Cyanidin 3-arabinoside

3-{[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1$l^{4}-chromen-1-ylium

C20H19O10 (419.09781740000005)


   

bromperidol

bromperidol

C21H23BrFNO2 (419.089609)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AD - Butyrophenone derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Bromperidol (R-11333) possesses antipsychotic activity, with a high affinity for central dopamine receptors D2. Bromperidol can kill Mycobacteria in a synergistic manner with Spectinomycin[1][2].

   
   
   

JWH 018 N-(5-bromopentyl) analog

JWH 018 N-(5-bromopentyl) analog

C24H22BrNO (419.0884662)


   
   
   

2-[[3,4-Dihydro-1-oxo-3-methyl-4,8-dihydroxy-5-chloro-1H-2-benzopyran-7-yl]carbonylamino]-3-phenylpropanoic acid

2-[[3,4-Dihydro-1-oxo-3-methyl-4,8-dihydroxy-5-chloro-1H-2-benzopyran-7-yl]carbonylamino]-3-phenylpropanoic acid

C20H18ClNO7 (419.0771748)


   

Cyanidin-3-O-alpha-arabinopyranoside

Cyanidin-3-O-alpha-arabinopyranoside

[C20H19O10]+ (419.09781740000005)


Acquisition and generation of the data is financially supported in part by CREST/JST.

   
   
   
   

Cyanidin-3-O-alpha-arabinoside

Cyanidin-3-O-alpha-arabinoside

[C20H19O10]+ (419.09781740000005)


Annotation level-1

   
   
   

4-Hydroxy-N-(2-diethylaminoethyl)benzamide

2-[(2E)-5-(furan-2-yl)-4-[(1E)-1-(furan-2-yl)-3-oxoprop-1-en-2-yl]-2-(furan-2-ylmethylidene)-3-oxo-2,3-dihydro-1H-pyrrol-1-yl]propanoic acid

C23H17NO7 (419.1004972)


   

Cyanidin 3-xyloside

3-{[(2S,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1$l^{4}-chromen-1-ylium

C20H19O10 (419.09781740000005)


   

Cyanidin 7-arabinoside

2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-[(3,4,5-trihydroxyoxan-2-yl)oxy]-1$l^{4}-chromen-1-ylium

C20H19O10 (419.09781740000005)


   

Methantheline Bromide

Methantheline Bromide

C21H26BrNO3 (419.10959460000004)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Mepenzolate bromide

Mepenzolate (Bromide)

C21H26BrNO3 (419.10959460000004)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   
   

2-[(3-iodo-6-nitroindazol-1-yl)methoxy]ethyl-trimethylsilane

2-[(3-iodo-6-nitroindazol-1-yl)methoxy]ethyl-trimethylsilane

C13H18IN3O3Si (419.0162148)


   

1-{2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-ethyl-[1,3]dioxolan-2-ylmethyl}-1H-[1,2,4]triazole

1-{2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-ethyl-[1,3]dioxolan-2-ylmethyl}-1H-[1,2,4]triazole

C20H19Cl2N3O3 (419.08034040000007)


   
   
   

3-(6-CHLORO-5-FLUOROPYRIMIDIN-4-YL)-2,(2,4-DIFLUORO PHENYL) - 1-(1H-1,2,4-TRIAZOLE-1-YL)BUTAN-2-OL HYDROCHLORIDE

3-(6-CHLORO-5-FLUOROPYRIMIDIN-4-YL)-2,(2,4-DIFLUORO PHENYL) - 1-(1H-1,2,4-TRIAZOLE-1-YL)BUTAN-2-OL HYDROCHLORIDE

C16H14Cl2F3N5O (419.052745)


   

benzyl (S)-2-(N-t-butoxycarbonylamino)-4-iodobutanoate

benzyl (S)-2-(N-t-butoxycarbonylamino)-4-iodobutanoate

C16H22INO4 (419.05935220000003)


   

1-(2,6-DICHLOROBENZYL)THIOETHYL-2-METHYL 5-PHENYLPYRROLE-3-CARBOXYLIC ACID

1-(2,6-DICHLOROBENZYL)THIOETHYL-2-METHYL 5-PHENYLPYRROLE-3-CARBOXYLIC ACID

C21H19Cl2NO2S (419.05134940000005)


   

1-Butyl-3-Methylimidazolium Bis(Trifluoromesulfonyl)imide

1-Butyl-3-Methylimidazolium Bis(Trifluoromesulfonyl)imide

C10H15F6N3O4S2 (419.0408142)


   
   

Ethyl 6-bromo-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate

Ethyl 6-bromo-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate

C19H18BrNO3S (419.0190698)


   

Phosphonium,(4-nitrophenyl)triphenyl-,chloride

Phosphonium,(4-nitrophenyl)triphenyl-,chloride

C24H19ClNO2P (419.0841874000001)


   

0,11-DIMETHOXY-6-METHYL-5,6-DIHYDRO-4H-DIBENZO[DE,G]QUINOLINE

0,11-DIMETHOXY-6-METHYL-5,6-DIHYDRO-4H-DIBENZO[DE,G]QUINOLINE

C10H15F6N3O4S2 (419.0408142)


   

6-iodonordihydrocapsaicin

6-iodonordihydrocapsaicin

C17H26INO3 (419.0957356)


   

Clopidogrel bisulfate

Clopidogrel bisulfate

C16H18ClNO6S2 (419.0264038)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively[1]. Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation[2].Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor[5].

   

iron(3+),tribenzoate

iron(3+),tribenzoate

C21H15FeO6 (419.021798)


   

1H-Benzimidazole,5,6-dimethyl-1-[[4-(1-pyrrolidinylsulfonyl)phenyl]sulfonyl]-(9CI)

1H-Benzimidazole,5,6-dimethyl-1-[[4-(1-pyrrolidinylsulfonyl)phenyl]sulfonyl]-(9CI)

C19H21N3O4S2 (419.09734260000005)


   

8-azido-5-ethyl-6-phenylphenanthridin-5-ium-3-amine,bromide

8-azido-5-ethyl-6-phenylphenanthridin-5-ium-3-amine,bromide

C21H18BrN5 (419.0745488)


   

Troriluzole

Troriluzole

C15H16F3N5O4S (419.08750520000007)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C26170 - Protective Agent > C1509 - Neuroprotective Agent

   
   

Methyl 2-(perfluorobenzamido)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate

Methyl 2-(perfluorobenzamido)-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxylate

C18H14F5NO3S (419.0614514)


   

(4-{[Allyl(methyl)amino]methyl}-1,1-biphenyl-4-YL)(4-bromophenyl)methanone

(4-{[Allyl(methyl)amino]methyl}-1,1-biphenyl-4-YL)(4-bromophenyl)methanone

C24H22BrNO (419.0884662)


   

Isoquinoline-5-sulfonic acid (2-(2-(4-chlorobenzyloxy)ethylamino)ethyl)amide

Isoquinoline-5-sulfonic acid (2-(2-(4-chlorobenzyloxy)ethylamino)ethyl)amide

C20H22ClN3O3S (419.10703320000005)


   

3-({4-[(5-Chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide

3-({4-[(5-Chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide

C17H14ClN5O4S (419.04549940000004)


   

3-[2-Bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile

3-[2-Bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile

C20H14BrN5O (419.0381654)


   
   

9-[2-benzyl-3,4-dihydroxy-5-(hydroxymethyl)-3-nitrooxolan-2-yl]-3H-purine-6-thione

9-[2-benzyl-3,4-dihydroxy-5-(hydroxymethyl)-3-nitrooxolan-2-yl]-3H-purine-6-thione

C17H17N5O6S (419.08995020000003)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels

   
   

Plavix

Plavix

C16H18ClNO6S2 (419.0264038)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

   

4-Fluorobenzoic acid 4-[[5-(5-quinolinyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

4-Fluorobenzoic acid 4-[[5-(5-quinolinyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C22H14FN3O3S (419.0739866)


   

N-[4-[5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-2-(4-methoxyphenyl)acetamide

N-[4-[5-(4-chlorophenyl)-1,2,4-oxadiazol-3-yl]phenyl]-2-(4-methoxyphenyl)acetamide

C23H18ClN3O3 (419.10366280000005)


   

N-[3-chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide

N-[3-chloro-4-(3-methyl-2,5-dioxo-3-phenyl-1-pyrrolidinyl)phenyl]-2-pyridinecarboxamide

C23H18ClN3O3 (419.10366280000005)


   
   

2-[[2-[[5-(4-Ethylanilino)-1,3,4-thiadiazol-2-yl]thio]-1-oxoethyl]amino]-3-thiophenecarboxamide

2-[[2-[[5-(4-Ethylanilino)-1,3,4-thiadiazol-2-yl]thio]-1-oxoethyl]amino]-3-thiophenecarboxamide

C17H17N5O2S3 (419.0544342)


   

N-[4-(diethylsulfamoyl)phenyl]-2-(2-oxo-1,3-benzothiazol-3-yl)acetamide

N-[4-(diethylsulfamoyl)phenyl]-2-(2-oxo-1,3-benzothiazol-3-yl)acetamide

C19H21N3O4S2 (419.09734260000005)


   

7-[(3-Bromophenyl)methyl]-1,3-dimethyl-8-(2-methylpropylamino)purine-2,6-dione

7-[(3-Bromophenyl)methyl]-1,3-dimethyl-8-(2-methylpropylamino)purine-2,6-dione

C18H22BrN5O2 (419.0956772)


   

N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-2-(2-pyrimidinylthio)acetamide

N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-2-(2-pyrimidinylthio)acetamide

C17H17N5O4S2 (419.0721922)


   

2-[(6-amino-3,5-dicyano-4-thiophen-2-yl-2-pyridinyl)thio]-N-(2-phenylethyl)acetamide

2-[(6-amino-3,5-dicyano-4-thiophen-2-yl-2-pyridinyl)thio]-N-(2-phenylethyl)acetamide

C21H17N5OS2 (419.0874472)


   

[4-(7-Chloro-4-quinolinyl)-1-piperazinyl]-(3,4-dichlorophenyl)methanone

[4-(7-Chloro-4-quinolinyl)-1-piperazinyl]-(3,4-dichlorophenyl)methanone

C20H16Cl3N3O (419.0358896)


   

[4-[[5-(2,4-Dichlorophenyl)-3-isoxazolyl]-oxomethyl]-1-piperazinyl]-(2-furanyl)methanone

[4-[[5-(2,4-Dichlorophenyl)-3-isoxazolyl]-oxomethyl]-1-piperazinyl]-(2-furanyl)methanone

C19H15Cl2N3O4 (419.04395700000003)


   

N-(6-amino-1-benzyl-2,4-dioxopyrimidin-5-yl)-2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-methylacetamide

N-(6-amino-1-benzyl-2,4-dioxopyrimidin-5-yl)-2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-N-methylacetamide

C16H17N7O3S2 (419.0834252)


   

N(2)-(1-hydroxy-2-oxoethyl)-GMP

N(2)-(1-hydroxy-2-oxoethyl)-GMP

C12H14N5O10P-2 (419.0478274)


   

5-Bromo-2-[[2-(4-tert-butylphenoxy)-1-oxoethyl]amino]benzoic acid methyl ester

5-Bromo-2-[[2-(4-tert-butylphenoxy)-1-oxoethyl]amino]benzoic acid methyl ester

C20H22BrNO4 (419.07321120000006)


   

N-{2-[(S)-(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide

N-{2-[(S)-(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide

C16H19F2N3O6S (419.09625780000005)


   

N-{2-[(R)-(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide

N-{2-[(R)-(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide

C16H19F2N3O6S (419.09625780000005)


   

6-Fluoro-3-pyridinecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

6-Fluoro-3-pyridinecarboxylic acid 4-[[5-(1-naphthalenyl)-1,3,4-oxadiazol-2-yl]thio]but-2-ynyl ester

C22H14FN3O3S (419.0739866)


   

1-S-[(1Z)-5-(methylsulfinyl)-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose

1-S-[(1Z)-5-(methylsulfinyl)-N-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-D-glucopyranose

C12H21NO9S3 (419.03784160000004)


   

2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C20H21NO7S (419.10386760000006)


   

2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1R,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C20H21NO7S (419.10386760000006)


   

2-[(1R,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1R,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C20H21NO7S (419.10386760000006)


   

2-[(1S,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1S,3R,4aR,9aS)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C20H21NO7S (419.10386760000006)


   

[(1R)-7-methoxy-1-thiophen-2-ylsulfonyl-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1R)-7-methoxy-1-thiophen-2-ylsulfonyl-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C19H21N3O4S2 (419.09734260000005)


   

[(1S)-7-methoxy-1-thiophen-2-ylsulfonyl-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

[(1S)-7-methoxy-1-thiophen-2-ylsulfonyl-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C19H21N3O4S2 (419.09734260000005)


   
   

(2S)-1-[(2E)-2-[(2S)-2,6-dicarboxy-2,3-dihydro-1H-pyridin-4-ylidene]ethylidene]-7-oxo-2,3-dihydropyrano[3,4-b]pyrrol-1-ium-2,5-dicarboxylic acid

(2S)-1-[(2E)-2-[(2S)-2,6-dicarboxy-2,3-dihydro-1H-pyridin-4-ylidene]ethylidene]-7-oxo-2,3-dihydropyrano[3,4-b]pyrrol-1-ium-2,5-dicarboxylic acid

C18H15N2O10+ (419.072667)


   
   

(2S,5S)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxyoxane-3,4,5-triol

(2S,5S)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxyoxane-3,4,5-triol

C20H19O10+ (419.09781740000005)


   

S-(2,2-Dichloro-1-hydroxy)ethyl glutathione

S-(2,2-Dichloro-1-hydroxy)ethyl glutathione

C12H19Cl2N3O7S (419.03207240000006)


   

[3-[1-Formyl-2-(2-furanyl)ethenyl]]-2-(2-furanyl)-5-(2-furanylmethylene)-4,5-dihydro-a-methyl-4-oxo-1H-pyrrole-1-acetic acid, 9CI

[3-[1-Formyl-2-(2-furanyl)ethenyl]]-2-(2-furanyl)-5-(2-furanylmethylene)-4,5-dihydro-a-methyl-4-oxo-1H-pyrrole-1-acetic acid, 9CI

C23H17NO7 (419.1004972)


   
   
   

Glucoraphenin

Glucoraphenin

C12H21NO9S3 (419.03784160000004)


A glucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 1-(methylsulfinyl)-5-[(sulfooxy)imino]pent-1-en-5-yl group at the anomeric sulfur.

   

(Rac)-PT2399

(Rac)-PT2399

C17H10F5NO4S (419.0250680000001)


(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specific hypoxia-inducible factor 2a (HIF-2α) inhibitor with an IC50 of 0.01 μM[1].

   

Kobe2602

Kobe2602

C14H9F4N5O4S (419.03113620000005)


Kobe2602 is a Ras-Raf interaction inhibitor. Kobe2602 inhibits the binding of H-Ras·GTP to c-Raf-1 RBD with a Ki of 149 μM. Kobe2602 has antitumor activity[1].

   

PT2399

PT2399

C17H10F5NO4S (419.0250680000001)


PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-2α PAS B domain with an IC50 of 6 nM. PT2399 displays potent antitumor activity in vivo[1][2][3].

   

WAY208466 (dihydrochloride)

WAY208466 (dihydrochloride)

C17H20Cl2FN3O2S (419.0637252)


WAY 208466 dihydrochloride is a potent and selective 5-HT6 receptor agonist (EC50=7.3 nM for the human 5-HT6 receptor). WAY-208466 dihydrochloride elevates cortical GABA levels in rat frontal cortex[1]. WAY 208466 dihydrochloride exhibits antidepressant and anxiolytic-like effects[2].

   

21-hydroxy-9-methoxy-17-(methylamino)-6-oxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1(13),3,8,10,14,17,20-heptaene-2,7,12,16,19-pentone

21-hydroxy-9-methoxy-17-(methylamino)-6-oxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁵,²⁰]henicosa-1(13),3,8,10,14,17,20-heptaene-2,7,12,16,19-pentone

C22H13NO8 (419.06411380000003)


   

{[5-(methylsulfanyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino}oxysulfonic acid

{[5-(methylsulfanyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino}oxysulfonic acid

C12H21NO9S3 (419.03784160000004)


   

[(z)-(5-methoxy-5-oxo-1-{[(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pentylidene)amino]oxysulfonic acid

[(z)-(5-methoxy-5-oxo-1-{[(2r,3r,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pentylidene)amino]oxysulfonic acid

C12H21NO11S2 (419.0555996)


   

3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium

3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-1λ⁴-chromen-1-ylium

[C20H19O10]+ (419.09781740000005)


   

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2r,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2r,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

[C20H19O10]+ (419.09781740000005)


   

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1λ⁴-chromen-1-ylium

[C20H19O10]+ (419.09781740000005)


   

7-(3,4-dihydroxyphenyl)-3,13,14-trihydroxy-10-oxo-6,9,19λ⁴-trioxapentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1(19),2,4,7,11,13,15,17-octaen-19-ylium

7-(3,4-dihydroxyphenyl)-3,13,14-trihydroxy-10-oxo-6,9,19λ⁴-trioxapentacyclo[13.3.1.0⁵,¹⁸.0⁸,¹⁷.0¹¹,¹⁶]nonadeca-1(19),2,4,7,11,13,15,17-octaen-19-ylium

[C22H11O9]+ (419.0403056)


   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(1z)-5-methanesulfinyl-1-(sulfoimino)pent-4-en-1-yl]sulfanyl}oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(1z)-5-methanesulfinyl-1-(sulfoimino)pent-4-en-1-yl]sulfanyl}oxane-3,4,5-triol

C12H21NO9S3 (419.03784160000004)


   

[(z)-[(4e)-5-(methylsulfanyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

[(z)-[(4e)-5-(methylsulfanyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pent-4-en-1-ylidene]amino]oxysulfonic acid

C12H21NO9S3 (419.03784160000004)